Campylobacteriosis medical therapy

Revision as of 16:05, 8 August 2015 by Ammu Susheela (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Campylobacteriosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Campylobacteriosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Campylobacteriosis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Campylobacteriosis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Campylobacteriosis medical therapy

CDC on Campylobacteriosis medical therapy

Campylobacteriosis medical therapy in the news

Blogs on Campylobacteriosis medical therapy

Directions to Hospitals Treating Campylobacteriosis

Risk calculators and risk factors for Campylobacteriosis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Medical therapy of campylobacteriosis mainly consist of supportive therapy. Antibiotics is reserved for severe cases of gastroenteritis and other extraintestinal infections

Medical Therapy

In most cases, reposition of liquid and electrolytes is enough. The use of antibiotics is controversial. Some studies show that erythromycin rapidly eliminates Campylobacter from the stool without affecting the duration of illness. Studies in children with dysentery due to C jejuni have shown benefit from early treatment with erythromycin. Treatment with antibiotics, therefore, depends on the severity of symptoms. Antimotility agents, such as loperamide, can lead to prolonged illness or intestinal perforation in any invasive diarrhea, and should be avoided.

Antimicrobial regimen

  • 1. Gastroenteritis[1]
  • Most patients donot require antibiotics and symptoms last < 1 week
  • 1.1 Indications for the treatment
  • Highfevers
  • Bloodystools
  • Prolonged illness > 1 week
  • Pregnancy
  • HIV and other immunosuppressed states
  • 1.2 Treatment regimen [2]
  • Preferred regimen (1):Erythromycin stearate 500 mg PO bid for 5 days
  • Preferred regimen (2): Ciprofloxacin 500 mg PO bid for 3–5 days
  • Alternative regimen (1): TMP-SMX DS PO bid for 3–5 days
  • Note (1): Campylobacter resistance to TMP-SMX common in tropics
  • Note (2): Extraintestinal infections should be treated for longer duration (e.g.,2-4 weeks)

References

  1. Bartlett, John (2012). Johns Hopkins ABX guide : diagnosis and treatment of infectious diseases. Burlington, MA: Jones and Bartlett Learning. ISBN 978-1449625580.
  2. Gilbert, David (2015). The Sanford guide to antimicrobial therapy. Sperryville, Va: Antimicrobial Therapy. ISBN 978-1930808843.


Template:WS